If you have questions about the work we do or are interested in helping us create a world free of psoriasis, please contact us using the information below.
General information Christy Langan, CEO
Finance and accounting Michele Borsa, Administrative Coordinator
Media Erika Fey, Senior Marketing and Communications Manager
Events and meetings Amanda Bledsoe, Senior Meeting and Events Planner
Partnership opportunities Tina A. Burke, Director of Corporate Relations
Education programs Nicora Gardner, MSW, Senior Education and Outreach Manager
Medical and scientific affairs Joelle van der Walt, PhD, Scientific Director
Peter van de Kerkhof, MD, PhD, Chief Medical Officer
UPCOMING EVENT Hot topics and challenging cases in psoriasis: A focus on pustular, biosimilars, pediatrics and treating in under-served areas Monday, june 10, 2019 1:30 – 4:30 pm milan, italy Register Now
IPC Psoriasis Review Newsletter IPC's bi-annual review of the latest manuscripts in the field of psoriasis. Read the latest issue
IPC's bi-annual review of the latest manuscripts in the field of psoriasis.
Psoriasis News Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz® (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology6/11/2019 9:58:00 AM Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments6/5/2019 12:03:00 PMCorticosteroid therapy is regarded as first-line therapy for treating mild psoriasis and recalcitrant lesions. Members of the IPC Topical Therapies Working Group reviewed available international topical corticosteroids guidelines in order to understand current information and to identify areas that would benefit from greater practical guidance for dermatologists. FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States4/29/2019 7:28:00 AM AbbVie Announces Approval of SKYRIZI™ for the Treatment of Psoriasis in US, Canada, Europe and Japan4/28/2019 8:26:00 PM More News